Document is current
Any future updates will be listed below
-
Authors
Dai, Qing
Xu, Antao https://orcid.org/0000-0003-4242-1869
Ye, Yan
Lv, Chenyin
Liu, Huaxiang
Li, Xiaomei
Miao, Jun
Min, Weiqi
Sun, Lingyun
Shi, Guixiu
Wang, Kuanting
Wang, Xiaofei
Wang, Xiaoxia
Wang, Yongfu
Wang, Yongqing
Wu, Huaxiang
Wu, Jian
Xue, Luan
Xu, Shengqian
Ye, Shanhui
Zhang, Xiao
Bao, Chunde https://orcid.org/0009-0007-8962-9727
Wang, Juan https://orcid.org/0000-0003-3825-1609
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04507659 at ClinicalTrials.govnct04507659 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
https://doi.org/10.1136/rmdopen-2024-004865
Documents that mention this clinical trial
Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
https://doi.org/10.1136/rmdopen-2024-004865
-
Funding
Funding for this research was provided by:
Suzhou Zelgen Biopharmaceuticals Co., Ltd
- License Information
